Cephlon/Teva seeks buyers for Mesoblast stake, CS in market
Stockbroker Credit Suisse was in the market with a substantial stake in Mesoblast on Tuesday afternoon.
The broker was looking to offload 29 million shares at $1.50 each on behalf of pharmaceutical company Cephlon, which was recently acquired by Teva.
The sale was designed to cut Cephlon/Teva's stake to less than 5 per cent of Mesoblast's shares on issue, investor sources told Street Talk.
The shares were being offered at an 8 per cent discount to their closing price on Tuesday.
The sale comes only two months after Mesoblast launched a $50.7 million equity raising which diluted Cephlon/Teva's stake.
Read more: http://www.copyright link/street-ta...ke-cs-in-market-20171023-gz6sm4#ixzz4wQrI6A5R
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-70
-
-
- There are more pages in this discussion • 17,958 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.03 |
Change
0.080(8.42%) |
Mkt cap ! $1.176B |
Open | High | Low | Value | Volume |
95.5¢ | $1.03 | 95.0¢ | $43.38M | 42.28M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 72752 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.03 | 205100 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 1.005 |
5 | 57985 | 1.000 |
1 | 50000 | 0.995 |
2 | 20525 | 0.990 |
1 | 10000 | 0.985 |
Price($) | Vol. | No. |
---|---|---|
1.035 | 190122 | 7 |
1.045 | 39714 | 5 |
1.050 | 21696 | 6 |
1.060 | 9750 | 2 |
1.065 | 5780 | 1 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online